Clinical Trial Update: Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a vaccine therapy to prevent HPV infection in younger cancer survivors has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Survivors
• Human Papillomavirus Infection Prevention

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cancer Survivor, Prevention of Human Papillomavirus Infection | Phase 2 | Status: COMPLETED | Results posted: 2020-04-30